Why AI is no miracle drug

Joe Castaldo, a business reporter focused on AI, and Sean Silcoff, a technology and life sciences reporter, dive into the complexities of using AI in drug development. They discuss the initial optimism surrounding AI’s potential to revolutionize drug discovery, juxtaposed with the stark realities faced by biotech companies over the last decade. The duo highlights significant challenges, such as managing conflicting AI models and the necessity for high-quality data, revealing that AI isn’t a foolproof answer to the long-standing issues in pharmaceutical research.